JPMorgan Chase & Co’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$596K Sell
480,502
-40,832
-8% -$50.6K ﹤0.01% 3984
2025
Q1
$615K Buy
521,334
+6,829
+1% +$8.06K ﹤0.01% 3903
2024
Q4
$942K Sell
514,505
-50,002
-9% -$91.5K ﹤0.01% 3832
2024
Q3
$960K Buy
564,507
+45,957
+9% +$78.1K ﹤0.01% 3669
2024
Q2
$710K Sell
518,550
-342,843
-40% -$470K ﹤0.01% 3688
2024
Q1
$3.23M Sell
861,393
-421,879
-33% -$1.58M ﹤0.01% 2838
2023
Q4
$12.6M Sell
1,283,272
-219,163
-15% -$2.15M ﹤0.01% 1938
2023
Q3
$12.5M Buy
1,502,435
+173,562
+13% +$1.45M ﹤0.01% 1819
2023
Q2
$17.7M Buy
1,328,873
+119,997
+10% +$1.6M ﹤0.01% 1628
2023
Q1
$14M Buy
1,208,876
+392,455
+48% +$4.54M ﹤0.01% 1735
2022
Q4
$6.68M Buy
816,421
+98,497
+14% +$806K ﹤0.01% 2185
2022
Q3
$4.17M Sell
717,924
-60,500
-8% -$351K ﹤0.01% 2454
2022
Q2
$3.44M Sell
778,424
-237,395
-23% -$1.05M ﹤0.01% 2649
2022
Q1
$9.24M Buy
1,015,819
+748,630
+280% +$6.81M ﹤0.01% 2104
2021
Q4
$5.47M Buy
267,189
+19,052
+8% +$390K ﹤0.01% 2512
2021
Q3
$6.34M Sell
248,137
-50,877
-17% -$1.3M ﹤0.01% 2417
2021
Q2
$10.5M Sell
299,014
-289,477
-49% -$10.1M ﹤0.01% 2107
2021
Q1
$19.6M Buy
588,491
+364,640
+163% +$12.1M ﹤0.01% 1617
2020
Q4
$5.81M Buy
223,851
+161,652
+260% +$4.19M ﹤0.01% 2318
2020
Q3
$610K Buy
62,199
+13,259
+27% +$130K ﹤0.01% 3305
2020
Q2
$169K Sell
48,940
-1,039,206
-96% -$3.59M ﹤0.01% 3737
2020
Q1
$3.33M Buy
1,088,146
+786,673
+261% +$2.41M ﹤0.01% 2269
2019
Q4
$1.55M Sell
301,473
-17,911
-6% -$92.1K ﹤0.01% 2840
2019
Q3
$1.65M Buy
319,384
+6,568
+2% +$33.9K ﹤0.01% 2831
2019
Q2
$1.88M Sell
312,816
-562,894
-64% -$3.38M ﹤0.01% 2706
2019
Q1
$6.33M Buy
875,710
+603,401
+222% +$4.36M ﹤0.01% 1978
2018
Q4
$2.02M Buy
272,309
+235,508
+640% +$1.74M ﹤0.01% 2638
2018
Q3
$199K Buy
36,801
+12,061
+49% +$65.2K ﹤0.01% 3871
2018
Q2
$88K Sell
24,740
-5,361
-18% -$19.1K ﹤0.01% 4123
2018
Q1
$62K Buy
30,101
+7,744
+35% +$16K ﹤0.01% 4081
2017
Q4
$59K Buy
+22,357
New +$59K ﹤0.01% 4080
2017
Q3
Sell
-34,370
Closed -$122K 4378
2017
Q2
$122K Sell
34,370
-66,040
-66% -$234K ﹤0.01% 3513
2017
Q1
$519K Sell
100,410
-31,051
-24% -$160K ﹤0.01% 3141
2016
Q4
$500K Buy
131,461
+27,382
+26% +$104K ﹤0.01% 3283
2016
Q3
$933K Buy
104,079
+49,169
+90% +$441K ﹤0.01% 2781
2016
Q2
$386K Buy
54,910
+25,346
+86% +$178K ﹤0.01% 3071
2016
Q1
$251K Sell
29,564
-11,103
-27% -$94.3K ﹤0.01% 3087
2015
Q4
$535K Buy
40,667
+29,880
+277% +$393K ﹤0.01% 2888
2015
Q3
$39K Buy
+10,787
New +$39K ﹤0.01% 3251
2015
Q2
Sell
-140,355
Closed -$819K 3472
2015
Q1
$819K Buy
140,355
+100,855
+255% +$589K ﹤0.01% 2900
2014
Q4
$310K Buy
+39,500
New +$310K ﹤0.01% 3168
2014
Q1
Sell
-15,891
Closed -$84K 3570
2013
Q4
$84K Sell
15,891
-23,217
-59% -$123K ﹤0.01% 3551
2013
Q3
$216K Buy
39,108
+28,255
+260% +$156K ﹤0.01% 3642
2013
Q2
$28K Buy
+10,853
New +$28K ﹤0.01% 3806